1.
Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-we...
by Oparil, Suzanne, MD
Clinical therapeutics, 2010, Vol.32 (7), p.1252-1269
2.
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
by Julius, Stevo
The Lancet (British edition), 2004, Vol.363 (9426), p.2022-2031
3.
Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial
by Weber, Michael A, Prof
The Lancet (British edition), 2013, Vol.381 (9866), p.537-545
4.
Effect of Antihypertensive Agents on Blood Pressure Variability: The Natrilix SR Versus Candesartan and Amlodipine in the Reduction of Systolic Blood Pressure in Hypertensive Patie...
by Zhang, Yi
Hypertension (Dallas, Tex. 1979), 2011, Vol.58 (2), p.155-160
5.
Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination an...
by Philipp, Thomas, MD
Clinical therapeutics, 1997, Vol.29 (4), p.563-580
6.
Triple Antihypertensive Therapy With Amlodipine, Valsartan, and Hydrochlorothiazide: A Randomized Clinical Trial
by Calhoun, David A
Hypertension (Dallas, Tex. 1979), 2009, Vol.54 (1), p.32-39
7.
Usefulness of Heart Rate to Predict Cardiac Events in Treated Patients With High-Risk Systemic Hypertension
by Julius, Stevo, MD, ScD
The American journal of cardiology, 2012, Vol.109 (5), p.685-692
8.
Effects of Candesartan Compared With Amlodipine in Hypertensive Patients With High Cardiovascular Risks: Candesartan Antihypertensive Survival Evaluation in Japan Trial
by Ogihara, Toshio
Hypertension (Dallas, Tex. 1979), 2008, Vol.51 (2), p.393-398
9.
Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): a randomised, parallel-group trial
by Brown, Morris J, Prof
The Lancet (British edition), 2011, Vol.377 (9762), p.312-320
10.
Treatment of Hypertension and Renal Injury Induced by the Angiogenesis Inhibitor Sunitinib Preclinical Study
by Lankhorst, Stephanie
Hypertension (Dallas, Tex. 1979), 2014, Vol.64 (6), p.1282-U260
11.
Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial
by Weber, Michael A
The Lancet (British edition), 2004, Vol.363 (9426), p.2049-2051
12.
Direct Renin Inhibition With Aliskiren in Obese Patients With Arterial Hypertension
by Jordan, Jens
Hypertension (Dallas, Tex. 1979), 2007, Vol.49 (5), p.1047-1055
13.
Renin Inhibition by Aliskiren Prevents Atherosclerosis Progression: Comparison With Irbesartan, Atenolol, and Amlodipine
by Nussberger, Jürg
Hypertension (Dallas, Tex. 1979), 2008, Vol.51 (5), p.1306-1311
14.
Electrocardiographic Left Ventricular Hypertrophy Predicts Cardiovascular Morbidity and Mortality in Hypertensive Patients: The ALLHAT Study
by Bang, Casper N
American journal of hypertension, 2017, Vol.30 (9), p.914-922
15.
Lercanidipine valuable effect on urine protein losses: the RED LEVEL study
by Robles, Nicolas Roberto
Current medical research and opinion, 2016, Vol.32 (sup2), p.29-34
16.
Drug Effects on Aldosterone/Plasma Renin Activity Ratio in Primary Aldosteronism
by Mulatero, Paolo
Hypertension (Dallas, Tex. 1979), 2002, Vol.40 (6), p.897-902
17.
Metabolic and Cardiovascular Effects of Switching Thiazides to Amlodipine in Hypertensive Patients With and Without Type 2 Diabetes (the Diuretics and Diabetes Control Study)
by Buscemi, Silvio
Metabolic syndrome and related disorders, 2020, Vol.18 (2), p.11-118
18.
Does a fixed-dose combination of amlodipine and atorvastatin improve persistence with therapy in the Australian population?
by Bartlett, Louise E.
Current medical research and opinion, 2018, Vol.34 (2), p.305-311
19.
The effects of amlodipine and S(-)-amlodipine on vascular endothelial function in patients with hypertension
by He, Yuquan
American journal of hypertension, 2014, Vol.27 (1), p.27-31
20.
Effectiveness of perindopril/amlodipine fixed dose combination in everyday clinical practice: results from the EMERALD study
by Vlachopoulos, C.
Current medical research and opinion, 2016, Vol.32 (9), p.1605-1610
